Scholarly Index
Tim F. Greten
National Cancer Institute; 53,176 total citations; 436 total publications; best world rank #86
National Cancer Institute
53,176Total citations
436Total publications
89H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Immune cells in cancer | Lifetime | 86 | US 36 | 99.37 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 170 | US 100 | 99.57 |
| Hepatocellular Carcinoma Treatment and Prognosis | Lifetime | 109 | US 42 | 99.53 |
| Immunotherapy and Immune Responses | Lifetime | 379 | US 197 | 99.35 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | Lifetime | 447 | US 137 | 98.20 |
| Colorectal Cancer Treatments and Studies | Lifetime | 859 | US 329 | 97.58 |
| Cancer Mechanisms and Therapy | Lifetime | 662 | US 265 | 93.97 |
| Liver physiology and pathology | Lifetime | 819 | US 242 | 94.55 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 292 | US 114 | 98.87 |
| Hepatocellular Carcinoma Treatment and Prognosis | 2021-2025 | 154 | US 35 | 97.99 |
| Cancer Genomics and Diagnostics | 2021-2025 | 501 | US 231 | 96.79 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | 2021-2025 | 202 | US 42 | 96.04 |
| Immune Cell Function and Interaction | 2021-2025 | 477 | US 183 | 94.36 |
| Immune cells in cancer | 2021-2025 | 673 | US 144 | 90.39 |
| IL-33, ST2, and ILC Pathways | 2021-2025 | 904 | US 292 | 74.63 |